Your search returned 2 results.

Results
	1.	Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. [electronic resource] by Metra, Marco Cotter, Gad Davison, Beth A Felker, G Michael Filippatos, Gerasimos Greenberg, Barry H Ponikowski, Piotr Unemori, Elaine Voors, Adriaan A Adams, Kirkwood F Dorobantu, Maria I Grinfeld, Liliana Jondeau, Guillaume Marmor, Alon Masip, Josep Pang, Peter S Werdan, Karl Prescott, Margaret F Edwards, Christopher Teichman, Sam L Trapani, Angelo Bush, Christopher A Saini, Rajnish Schumacher, Christoph Severin, Thomas Teerlink, John R Producer: 20130301 In: Journal of the American College of Cardiology vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. [electronic resource] by Teerlink, John R Cotter, Gad Davison, Beth A Felker, G Michael Filippatos, Gerasimos Greenberg, Barry H Ponikowski, Piotr Unemori, Elaine Voors, Adriaan A Adams, Kirkwood F Dorobantu, Maria I Grinfeld, Liliana R Jondeau, Guillaume Marmor, Alon Masip, Josep Pang, Peter S Werdan, Karl Teichman, Sam L Trapani, Angelo Bush, Christopher A Saini, Rajnish Schumacher, Christoph Severin, Thomas M Metra, Marco Producer: 20130124 In: Lancet (London, England) vol. 381 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)